Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice.
Emily P McCannJennifer A FifitaNatalie GrimaJasmin GalperPrachi MehtaSarah E FreckletonKatharine Y ZhangLyndal HendenAlison L HoganSandrine Chan Moi FatSharlynn Sl WuCyril J JagarajBritt A BerningKelly Louise WilliamsNatalie A TwineDenis BauerOlivier PiguetJohn HodgesJohn B J KwokGlenda M HallidayMatthew C KiernanJulie AtkinDominic B RoweGarth A NicholsonAdam K WalkerIan P BlairShu YangPublished in: Journal of neurology, neurosurgery, and psychiatry (2019)
Genetic variation in CHCHD10 is not a common cause of ALS/FTD in Australia. However, we showed that in humans, CHCHD10 may play a neuron-specific role and a loss of CHCHD10 function may be linked to ALS and/or FTD. Our data from the rNLS TDP-43 transgenic mice suggest that a decrease in CHCHD10 levels is a late event in aberrant TDP-43-induced ALS/FTD pathogenesis.